Treatment Strategy to Prevent Mood Disorders Following Traumatic Brain Injury
Status:
Completed
Trial end date:
2014-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to examine the efficacy of sertraline to prevent the onset of
mood and anxiety disorders during the first six months after traumatic brain injury.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Baylor College of Medicine
Collaborator:
National Institute of Neurological Disorders and Stroke (NINDS)